President Trump's Drug Pricing Policy and Pharma Stocks
Policy shifts around president trump's drug pricing could squeeze pharma profits and shift stock dynamics. This guide...
Curbing bad spending requires actionable steps like setting limits, automating savings, and choosing mindful alternatives to impulsive buys.
13,525 articlesPolicy shifts around president trump's drug pricing could squeeze pharma profits and shift stock dynamics. This guide...
Regulators are tightening control over cash-to-crypto channels as Bitcoin ATMs—the devices that brought crypto into e...
ATTOM's Q1 2026 Housing Impact Report places Florida and California counties at the top of housing market risk, signa...
Mortgage lenders are navigating a regulatory minefield as AI-generated marketing enters the mortgage space. New rules...
A new Washington state law requires residential listings to be publicly marketed, limiting private and exclusive sale...
A new push among MLS networks aims to form a national alliance to standardize data licensing, promising faster loan o...
Lawmakers push a federal framework for digital assets to reduce regulatory fragmentation. The Digital Asset Market Cl...
Industry leaders urge a shift from hype to honest storytelling to rebuild trust in reverse mortgages. This report out...
TRM Labs identifies CoinEx as the largest exit channel for Iran linked crypto flows, tracing billions since 2019 and ...
The BIS warns that AI-driven hype could trigger a stock-market pullback and spill into credit markets, threatening gl...
Taiwan enacted a comprehensive stablecoin framework on June 30, 2025, mandating full reserves, domestic custody, and ...
A federal judge granted Alibaba a temporary reprieve from the Defense Department lobbying ban as she weighs the compa...